Close Menu

NEW YORK (GenomeWeb) – San Francisco-based Linkage Biosciences today announced the launch of a wholly-owned European subsidiary based in Geneva.

The move is in response to global demand for LinkSeq molecular tissue typing technology, the firm said in a statement. The real-time PCR-based human leukocyte antigen testing technology covers 12,000 alleles in a single test, the firm said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Mainichi reports that 43 percent of Japanese individuals said they did not want to eat agricultural products that had been modified using gene-editing tools.

Two US Department of Agriculture research departments are moving to the Kansas City area, according to the Washington Post.

Slate's Jane Hu compares some at-home genetic tests to astrology.

In PLOS this week: analysis of polygenic risk scores for skin cancer, chronic pain GWAS, and more.